These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4766788)

  • 21. [Determination of the power of galenic-pharmaceutical industries--important stage in the planning of their production].
    Vasil'chenko OG
    Farm Zh; 1970; 25(4):70-5. PubMed ID: 5487996
    [No Abstract]   [Full Text] [Related]  

  • 22. [Manufacturing and control in pharmaceutical industry. Introduction into manufacturing control. Introduction].
    Hippenmeier F
    Pharm Acta Helv; 1972; 47(11):625-8. PubMed ID: 4657531
    [No Abstract]   [Full Text] [Related]  

  • 23. Expectations for process validation: industry perspectives.
    Francis R
    Dev Biol (Basel); 2003; 113():9-14. PubMed ID: 14620847
    [No Abstract]   [Full Text] [Related]  

  • 24. A new approach to quality training.
    Betts WA
    J Parenter Sci Technol; 1981; 35(5):248-50. PubMed ID: 7299602
    [No Abstract]   [Full Text] [Related]  

  • 25. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 2008; (948):1-138. PubMed ID: 18557474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality: an old solution to new discovery dilemmas?
    Volsen SG; Kent JM; Masson M
    Drug Discov Today; 2004 Nov; 9(21):903-5. PubMed ID: 15501718
    [No Abstract]   [Full Text] [Related]  

  • 27. [Practical realization of manufacturing control in Switzerland].
    Witschi T
    Pharm Acta Helv; 1972; 47(11):637-47. PubMed ID: 4657533
    [No Abstract]   [Full Text] [Related]  

  • 28. [Guidelines for introducing new drugs for medical use in Poland and control of their quality].
    Danysz A
    Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1673-4. PubMed ID: 6522321
    [No Abstract]   [Full Text] [Related]  

  • 29. [Standards of good manufacturing. Autoinspection].
    Anitco G; Guiggi A; Mazzoldi G; Paravidino C; Vianello GS
    Boll Chim Farm; 1975 Apr; 114(4):190-200. PubMed ID: 1131322
    [No Abstract]   [Full Text] [Related]  

  • 30. The other side of process validation.
    Agalloco JP
    J Parenter Sci Technol; 1986; 40(6):251-2. PubMed ID: 3819977
    [No Abstract]   [Full Text] [Related]  

  • 31. International Conference on Harmonisation; guidance on Q10 Pharmaceutical Quality System; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Apr; 74(66):15990-1. PubMed ID: 19507321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Some engineering problems on developing production industry of modern traditional Chinese medicine].
    Qu HB; Cheng YY; Wang YS
    Zhongguo Zhong Yao Za Zhi; 2003 Oct; 28(10):904-6, 939. PubMed ID: 15620174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Forty-first report.
    World Health Organization
    World Health Organ Tech Rep Ser; 2007; (943):1-156. PubMed ID: 17621973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Roadmap for implementation of quality by design (QbD) for biotechnology products.
    Rathore AS
    Trends Biotechnol; 2009 Sep; 27(9):546-53. PubMed ID: 19647883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent applications of Chemical Imaging to pharmaceutical process monitoring and quality control.
    Gowen AA; O'Donnell CP; Cullen PJ; Bell SE
    Eur J Pharm Biopharm; 2008 May; 69(1):10-22. PubMed ID: 18164926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Current challenges for the pharmaceutical research industry].
    Chalchat B
    Ann Pharm Fr; 1993; 51(1):16-25. PubMed ID: 8215118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Responsibility for drug testing and control].
    Büchi J
    Pharm Acta Helv; 1968 Sep; 43(9):619-27. PubMed ID: 5718866
    [No Abstract]   [Full Text] [Related]  

  • 38. [The organization of a research laboratory in pharmaceutical industry].
    Fishburn AG
    Ann Pharm Fr; 1970 Feb; 28(2):93-8. PubMed ID: 5429058
    [No Abstract]   [Full Text] [Related]  

  • 39. [Bioengineering, pharmaceutical development and control of contamination: the three components of pharmaceutical engineering and their influence in advanced methods of production].
    Ghirardini M; Falini R
    Boll Chim Farm; 1986 Sep; 125(9):328-38. PubMed ID: 3828099
    [No Abstract]   [Full Text] [Related]  

  • 40. Improving drug manufacturing with process analytical technology.
    Rodrigues LO; Alves TP; Cardoso JP; Menezes JC
    IDrugs; 2006 Jan; 9(1):44-8. PubMed ID: 16374733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.